PSMA PET/CT imaging and its application to prostate cancer treatment

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: PSMA PET/CT imaging and its application to prostate cancer treatment ; day:3 ; month:9 ; year:2024 ; pages:1-12
Japanese journal of radiology ; (3.9.2024), 1-12

Classification: Medizin, Gesundheit

Creator: Otani, Tomoaki
Nakamoto, Ryusuke
Umeoka, Shigeaki
Nakamoto, Yuji

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11604-024-01646-9

URN: urn:nbn:de:101:1-2411261053452.901438856177

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Otani, Tomoaki
Nakamoto, Ryusuke
Umeoka, Shigeaki
Nakamoto, Yuji
SpringerLink (Online service)

Other Objects (12)

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PSMA PET/CT imaging and its application to prostate cancer treatment

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Related objects

Reset password